A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma
2017 ◽
Vol 182
(3)
◽
pp. 429-433
◽
Guy Pratt
◽
Christina Yap
◽
Ceri Oldreive
◽
Daniel Slade
◽
Rebecca Bishop
◽
...
2019 ◽
Vol 6
(1)
◽
pp. e38-e47
◽
Matthew S Davids
◽
Haesook T Kim
◽
Alyssa Nicotra
◽
Alexandra Savell
◽
Karen Francoeur
◽
...
2010 ◽
Vol 123
(3)
◽
pp. 194-196
◽
Juanah Addada
◽
Parameswaran Anoop
◽
John G. Swansbury
◽
Andy Wotherspoon
◽
J. Meirion Thomas
◽
...
2016 ◽
Vol 34
(15_suppl)
◽
pp. TPS7583-TPS7583
◽
Steven Le Gouill
◽
Andrew Davies
◽
Kamal Bouabdallah
◽
David Chiron
◽
Simon Rule
2015 ◽
Vol 75
(7)
◽
pp. 769-776
◽
Esther S. Kim
◽
Sohita Dhillon
2020 ◽
Vol 3
(3)
◽
pp. 27-31
Dr. Rahul Ranka
◽
Dr. Beena Brahmbhatt
2010 ◽
Vol 101
(1)
◽
pp. 196-200
◽
Takashi Watanabe
◽
Harumi Kato
◽
Yukio Kobayashi
◽
Satoshi Yamasaki
◽
Yuriko Morita-Hoshi
◽
...
2014 ◽
Vol 25
(10)
◽
pp. 2020-2024
◽
D.J. Inwards
◽
P.A. Fishkin
◽
B.R. LaPlant
◽
M.T. Drake
◽
P.J. Kurtin
◽
...
2010 ◽
Vol 151
(1)
◽
pp. 47-53
◽
Jorge E. Romaguera
◽
Luis E. Fayad
◽
Peter McLaughlin
◽
Barbara Pro
◽
Alma Rodriguez
◽
...
Close
Export Citation Format
Close
Share Document
Close